$0.5900
-0.0154-2.54%
Last update: Oct 30, 7:30 PM
Rani Therapeutics Holdings Inc (RANI) Stock Price, Quote, News & History
RANINASDAQ
Ericsson shares surged 10.9% premarket after beating Q3 earnings and sales estimates; other small-cap stocks saw sharp gains and losses.
You can purchase shares of Rani Therapeutics Hldgs (NASDAQ:RANI) through any online brokerage.
Other companies in Rani Therapeutics Hldgs’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Rani Therapeutics Hldgs has a consensus price target of $9.18.
The stock price for Rani Therapeutics Hldgs (NASDAQ: RANI) is $0.6014 last updated October 30, 2026 at 7:30 PM EDT.
There are no upcoming dividends for Rani Therapeutics Hldgs.
Rani Therapeutics Hldgs does not have any upcoming earnings scheduled.
There is no upcoming split for Rani Therapeutics Hldgs.
Rani Therapeutics Hldgs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to...
